Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 794 participants.
Also called NCT07168278
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 794 participants
- Registry
-
NCT07168278
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07168278. Randomized; single masking; primary purpose treatment. Start 2025-11-01 (anticipated); primary completion 2028-03-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT
- Acronym
- TNK LATE
- Condition
- Acute Ischemic Stroke
- Condition
- Large Vessel Occlusion
- Condition
- Tenecteplase
- Condition
- Thrombolysis
- Intervention (Drug)
- TNK
- Intervention (Drug)
- Standard medical treatment
- Lead sponsor
- The First Affiliated Hospital of University of Science and Technology of China
Record details
- Record id
cardio:ct-nct07168278- Content hash
b0dff4de57d9d8ac83692a7705383cbd0bf00130f8b852ac0ef2121504609509